Chief Technology Officer
Dr. Adi Zuloff-Shani has served as Chief Technologies Officer at Therapix since February 2016, bringing with her more than 15 years of experience as an R&D executive. From 2012 until 2016, Dr. Zuloff–Shani served as a Vice President of Development at Macrocure Ltd. (NASDAQ: “MCUR”) where, aside from leading all research and development activities, she interacted, and was involved, with the activities of all departments including clinical, operations, quality assurance, quality control, finance, and regulatory affairs. Prior to that, Dr. Zuloff-Shani spent eight years as the Senior Scientist in the Research & Development Unit of Magen David Adom’s National Blood Services. Dr. Zuloff-Shani holds a Ph.D. in human biology and immunology from Bar-Ilan University, Israel.